JPRN-UMIN000030408
Completed
未知
Evaluation of efficacy due to response by FDG-PET in breast cancers treated with neoadjuvant chemotherapy - PET NAC
ConditionsBreast cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Breast cancer
- Sponsor
- Hyogo College of Medicine
- Enrollment
- 199
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients with Li\-Fraumeni syndrome.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
sefulness of FDG-PET/CT to predict the response after anti-PD-1 antibody in patients with previously treated advanced non-small cell lung cancer: a multi-institutional studyPreviously treated advanced non-small cell lung cancerJPRN-UMIN000031009Gunma University120
Recruiting
Not Applicable
sefulness of FDG-PET/CT to predict the response after nivolumab in patients with previously treated advanced non-small cell lung cancerPreviously treated advanced non-small cell lung cancerJPRN-UMIN000020814Gunma30
Unknown
Not Applicable
sefulness of FDG-PET/CT to predict the response after pembrolizumab in patients with PD-L1 positive advanced non-small cell lung canceradvanced non-small cell lung cancerJPRN-UMIN000026730Gunma University Hospital50
Completed
Not Applicable
Assessing the efficacy of FDG-PET(18F-fluorodeoxy glucose positron emission tomography) in the early detection of RCC (Renal cell carcinoma) in patients with ESRD(End stage renal disease)Renal cell carcinoma related with end stage renal diseaseJPRN-UMIN000009336Gunma University Hospital department of nuclear medecine150
Recruiting
Phase 2
Phase II study of interim FDG-PET-guided response-adapted therapy in pediatric patients with Hodgkin's lymphoma (HL-14)s lymphomaHodgkin'JPRN-UMIN000019093Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)50